| 2024-01-30 |
Improving Interoperability in Healthcare: A User-Friendly International Standard Data Conversion Framework |
Lecture Notes in Electrical Engineering. 2024 Jan 30;1133:326-335. |
 |
| 2024-01-30 |
Development of an artificial intelligence-based precise nutrition and dietary management model with nutrient intake recommendation framework |
Lecture Notes in Electrical Engineering. 2024 Jan 30;1133:336-344. |
|
| 2023-11-28 |
MPO and trh within leukemia stem cells increased chemosensitivity in acute myeloid leukemia: A single-cell RNA sequencing approach |
Blood. 2023 Nov 28;142(Suppl. 1):Meeting Abstract 4323. |
|
| 2023-11 |
ILLUMINATE: Efficacy and safety of durvalumab-tremelimumab and chemotherapy in EGFR mutant NSCLC following progression on EGFR inhibitors |
Journal of Thoracic Oncology. 2023 Nov;18(11, Suppl.):S63. |
|
| 2023-08-03 |
Association between dietary patterns, anthropometric status, lifestyle, and bone mineral density among postmenopausal women in Taiwan: A cross-sectional study |
Annals of Nutrition and Metabolism. 2023 Aug 03;79(Suppl. 1):926. |
|
| 2022-02 |
What can the anti-apoptotic molecule, BIRC5/Survivin, do in the autophagic world? |
Cancer Science. 2022 Feb;113(S1):41. |
|
| 2021-10 |
Pathogenic role of specific macrophage and fibroblast subpopulations in acne keloidalis identified by single cell RNA sequencing |
Journal of Investigative Dermatology. 2021 Oct;141(10):S211. |
|
| 2021-07 |
A phase I study of biweekly abraxane in combination with oxaliplatin and oral S-1/leucovorin as first line treatment for advanced gastric, pancreatic and biliary tract cancers |
Annals of Oncology. 2021 Jul;32(Suppl. 3):S146-S147. |
|
| 2021-07 |
Nivolumab plus ipilimumab as neoadjuvant therapy for potentially resectable hepatocellular carcinoma |
Annals of Oncology. 2021 Jul;32(Suppl. 3):S141-S141. |
|
| 2021-05 |
Differences in gut microbiota profiles and functions between end-stage kidney disease and healthy populations |
Nephrology Dialysis Transplantation. 2021 May;36(Suppl.):I54-I55. |
|
| 2019-05 |
Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients |
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number 1084. |
|
| 2018-03-01 |
Vocal analysis of speech in adults with autism spectrum disorders |
Acoustical Science and Technology. 2018 Mar 1;39(2):154-157. |
|
| 2018-01 |
Epigenetic regulation of LDHA dictates the gemcitabine resistance in pancreatic cancer |
Cancer Science. 2018 Jan;109(Suppl. 1):1146. |
|
| 2016-02 |
JAK2 overexpression is a prognostic indicator for worse outcome in nasopharyngeal carcinoma and is independent of JAK2 exon 12 and JAK2 V617F mutation |
Laboratory Investigation. 2016 Feb;96(Suppl. 1):325A. |
|
| 2016-02 |
JAK2 overexpression is a prognostic indicator for worse outcome in nasopharyngeal carcinoma and is independent of JAK2 exon 12 and JAK2 V617F mutation |
Modern Pathology. 2016 Feb;29(Suppl. 2):325A. |
|
| 2014-12 |
Studying the molecular mechanism underlying dissemination of pancreatic ductal adenocarcinoma after surgical resection |
Biomarkers and Genomic Medicine. 2014 Dec;6(4):196. |
|
| 2014-10 |
Amacr gene amplification and protein overexpression in primary imatinib-naive gastrointestinal intestinal stromal tumors |
Annals of Oncology. 2014 Oct;25:Article number P1-2-1. |
|
| 2014-05 |
AMACR overexpression is associated with clinical and biological aggressiveness in urothelial carcinomas of the upper urinary tract and urinary bladder |
European Journal of Cancer. 2014 May;50(Suppl. 4):e35. |
|
| 2014-05 |
MMP11 overexpression: Poor prognosis in patients with urothelial carcinoma of the upper tract and urinary bladder |
European Journal of Cancer. 2014 May;50(Suppl. 4):e43. |
|
| 2014-05 |
PTP4A3 overexpression predicts clinical aggressiveness in urothelial carcinoma |
European Journal of Cancer. 2014 May;50(Suppl. 4):e42-e43. |
|
| 2014-05 |
Cyclin-dependent kinase 4 overexpression confers an independent prognosticator of nasopharyngeal carcinoma |
European Journal of Cancer. 2014 May;50(Suppl. 4):e68. |
|
| 2014-05 |
CSF2 overexpression as a poor prognostic factor in patients with urothelial carcinoma of the upper urinary tract and urinary bladder |
European Journal of Cancer. 2014 May;50(Suppl. 4):e35-e36. |
|
| 2014-05 |
Overexpression of DPP4 is a poor prognostic factor for patients with urothelial carcinoma of the upper urinary tract and urinary bladder |
European Journal of Cancer. 2014 May;50(Suppl. 4):e39. |
|
| 2014-02 |
CDCA5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tract and urinary bladder |
Modern Pathology. 2014 Feb;27(Suppl. 2):220A. |
|
| 2014-02 |
HOXC6 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma |
Modern Pathology. 2014 Feb;27(Suppl. 2):331A. |
|
| 2014-02 |
SLC14A1 down-regulation is associated with poor clinical outcome in patients with urothelial carcinoma of upper urinary tracts and urinary bladder |
Modern Pathology. 2014 Feb;27(Suppl. 2):245A. |
|
| 2014-02 |
Characterization of the clinical, biological, and therapeutic relevance of EZH2 overexpression in myxofibrosarcoma |
Modern Pathology. 2014 Feb;27(Suppl. 2):22A. |
|
| 2014-02 |
CDCA5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tract and urinary bladder |
Laboratory Investigation. 2014 Feb;94(S1):220A. |
|
| 2014-02 |
SLC14A1 down-regulation is associated with poor clinical outcome in patients with urothelial carcinoma of upper urinary tracts and urinary bladder |
Laboratory Investigation. 2014 Feb;94(S1):245A. |
|
| 2014-02 |
HOXC6 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma |
Laboratory Investigation. 2014 Feb;94(S1):331A. |
|
| 2014-02 |
Characterization of the clinical, biological, and therapeutic relevance of EZH2 overexpression in myxofibrosarcoma |
Laboratory Investigation. 2014 Feb;94(S1):22A. |
|
| 2013-10 |
STMN1 overexpression as a poor prognostic factor in patients with Nasopharyngeal Carcinoma |
International Journal of Radiation Oncology Biology Physics. 2013 Oct;87(2, Supple. 1):S666-S667. |
|
| 2013-02 |
GFBP5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder |
Modern Pathology. 2013 Feb;26(Suppl. 2):230A. |
|
| 2013-02 |
Periostin overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma |
Modern Pathology. 2013 Feb;26(Suppl. 2):308A. |
|
| 2013-02 |
TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma |
Modern Pathology. 2013 Feb;26(Suppl. 2):308A. |
|
| 2013-02 |
Angiomatoid fibrous histiocytoma: Clincopathological and molecular characterization with emphasis on variant histomorphology |
Laboratory Investigation. 2013 Feb;93(Suppl. 1):14A. |
|
| 2013-02 |
TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma |
Laboratory Investigation. 2013 Feb;93(Suppl. 1):308A. |
|
| 2013-02 |
GFBP5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder |
Laboratory Investigation. 2013 Feb;93(Suppl. 1):230A. |
|
| 2013-02 |
Angiomatoid fibrous histiocytoma: Clincopathological and molecular characterization with emphasis on variant histomorphology |
Modern Pathology. 2013 Feb;26(Suppl. 2):14A. |
|
| 2013-02 |
Periostin overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma |
Laboratory Investigation. 2013 Feb;93(Suppl. 1):308A. |
|
| 2011-05 |
Size effect on tumor treatment with PEGylated liposomal drugs in a tumor-bearing mouse model |
Journal of Nuclear Medicine. 2011 May;52(Suppl. 1):Meeting Abstract 1737. |
|
| 2011-04 |
Early Treg suppression by a Listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer |
Journal of Immunology. 2011 Apr;186(Suppl. 1):Meeting Abstract 165.49. |
|
| 2011-04 |
SOX1 functions as a tumor suppressor through antagonizing WNT/beta-catenin signaling pathway in hepatocellular carcinoma |
Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 2199. |
|
| 2009-11 |
Characterization of three tyrosine kinase-related gene mutations at the EGFR exons 19-21 and amplification of the EGFR gene in colorectal cancer patients |
Journal of Molecular Diagnostics. 2009 Nov;11(6):654-655. |
|
| 2009-07 |
Down-regulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome |
Oral Oncology Supplement. 2009 Jul;3(1):73. |
|
| 2009-05 |
Cellular and functional heterogeneity of the sarcomatoid renal cell carcinoma cell line RCC52 with total loss of HLA class I: A system to study mesenchymalepithelial transition |
Cancer Research. 2009 May;69:Abstract number 222. |
|
| 2009-05 |
Characterization of naturally occurring floating cells and adherent cells within the CEA-producing UP-LN1 carcinoma cell line in vitro: Identification of cancer stem cells with metastatic potential |
Cancer Research. 2009 May;69:Abstract number 188. |
|
| 2009-05 |
The basal body gene, RPGRIP1L, is a candidate tumor suppressor gene on chromosome 16q12.2 in human hepatocellular carcinoma |
Cancer Research. 2009 May;69(9):Meeting Abstract 4950. |
|
| 2009-05 |
Evaluation therapeutic efficacy of In111-VNB-liposome with dual reporter gene in human colorectal carcinoma HT-29 xenografts |
Journal of Nuclear Medicine. 2009 May;50(Suppl. 2):Meeting Abstract 2306. |
|
| 2009-05 |
Molecular imaging-based passive targeted therapeutic efficacy with pegylated liposome encapsulated with 111In and vinorelbine in colon carcinoma xenografts |
Journal of Nuclear Medicine. 2009 May;50(Suppl. 2):Meeting Abstract 2303. |
|
